Vanda Pharmaceuticals Inc. (VNDA) Expected to Post Quarterly Sales of $38.35 Million

Vanda Pharmaceuticals Inc. (VNDA) Expected to Post Quarterly Sales of $38.35 Million


Wall Street brokerages expect Vanda Pharmaceuticals Inc. to report $38.35 million in sales for the current quarter, according to Zacks . Two analysts have issued estimates for Vanda Pharmaceuticals' earnings.



from Biotech News